BriaCell Therapeutics Corp. (BCTX)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Changes In Shareholders' Equity | ||
| Consolidated Statements of Operations and Comprehensive Loss (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Changes In Shareholders' Equity (deficit) | ||
| Consolidated Statements of Cash Flows (P) | ||
| Consolidated Statements of Changes In Shareholders' Equity (deficit) (P) | ||
| Notes | ||
| Accrued Expenses and Other Payables | — |
|
| Amounts Receivable and Prepaid Expenses | — |
|
| Basic and Diluted Net Loss Per Share | ||
| Contingent Liabilities and Commitments | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Fair Value Measurements | ||
| Financial Expense, Net | — |
|
| Financial Income (expenses), Net | — |
|
| Financial Income, Net | ||
| General | ||
| General and Going Concern | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets, Net | — |
|
| Intangible Assets. Net | — |
|
| Investment In Bc Therapeutics Inc | — |
|
| Investment In Bc Therapeutics Inc. | ||
| Long-lived Assets By Geographic Location | — |
|
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses | — |
|
| Property and Equipement, Net | — |
|
| Related Party Transactions and Balances | — |
|
| Research, Development, and Clinical Trial Expenses, Net | — |
|
| Share-based Compensation | ||
| Shareholders Equity | ||
| Significant Accounting Policies | ||
| Subsequent Events | ||
| Taxes On Income | — |
|